Follow us on:
Breaking News
December 24, 2025
Breaking News
Breaking News
New This Month at Contract Pharma
Rentschler_CP_BrandedContent_0925_ThisWeekAt

Symbiosis Begins Commercial Manufacturing at Stirling, UK Facility

 
Symbiosis Stirling

Manufactures first 10,000 vial batch to support the development of a cancer immunotherapy in Phase III trials.
Read More >>

Headlines

Breaking News

Samsung Biologics Acquires Human Genome Sciences from GSK

Secures its first U.S.-based manufacturing site, strengthening and diversifying its global supply network.

SPONSOR

[VIDEO] An Inside Look at Integrated Process Solutions at Glatt’s NJ Site

Brian McCollum walks us through Glatt’s capabilities and technologies available at its Ramsey, NJ site from development to commercialization.

Breaking News
Collaborations & Alliances

Chitose, Fujifilm Biosciences Partner to Advance Biopharmaceutical Manufacturing

Alliance combines high performing CHO-MK cells and GMP-manufactured culture media.

Breaking News
Collaborations & Alliances

Rectify Pharmaceuticals, Boehringer Ingelheim Partner to Accelerate Treatments for CKD

The collaboration leverages Rectify’s PFM platform to develop oral, small molecules that enhance ABCC6 protein function and reduce calcification.

SPONSOR

Beyond Protection: Evolving Trends In Secondary Packaging

Drawing insights from industry leaders and results from an in-depth Contract Pharma reader survey, this eBook provides a timely snapshot of what matters most to today’s packaging decision-makers.

IQVIA_eBook_0925_650x250

Contract Pharma Conference

Contracting & Outsourcing 2025: Q&A with John Bender of Woodstock

Vice President of Business Development shares insight on industry trends and bringing drugs to market faster.

SPONSOR

[VIDEO] Contract Pharma Sits Down with Quotient Sciences Team This March

Vanessa Zann and Andrew Parker share insights on poorly soluble APIs, approaches for modified release formulation development, and navigating accelerated approval pathways.

Featured Resources

Solution Center SPOTLIGHT

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway, from candidate selection through commercial manufacturing. We offer global services for drug substance synthesis and manufacturing, formulation development, clinical trials and clinical & commercial manufacturing.